What services does Auxilife provide?

Auxilife is a full-service agrochemical regulatory consultancy. We provide end-to-end regulatory support for the registration and compliance of Plant Protection Products (PPP), Biocides, Bio-stimulants, Fertilizers, Industrial and Specialty Chemicals, and OMRI certification for organic crop products. Our comprehensive services include regulatory strategy consulting, dossier preparation and compilation, data gap analysis, study monitoring, submission management, and post-approval compliance support.

Why should we choose Auxilife over other regulatory consultants?

Auxilife combines deep expert knowledge with a truly global reach. We are not just consultants; we are your strategic partners. Our advantages include expertise with decades of combined experience navigating complex regulatory frameworks, a one-stop solution for managing multiple country registrations through a single point of contact, a global network with direct liaison with regulatory authorities worldwide, and efficiency in streamlining processes to avoid costly delays and achieve compliance faster.

In which countries and regions can you help us get our products registered?

We have direct expertise and a strong network of partners in a vast number of key markets, including Europe (European Union and United Kingdom), Asia (India, China, Japan, Singapore), Africa (Kenya, South Africa, and other major regions), Americas (United States), Pacific (Australia), and other key markets like Morocco and Turkey. We can manage registrations in these countries and many others through our global partner network.

How long does the registration process typically take?

The timeline varies significantly by country, product type, and complexity. For example, a biostimulant registration in the EU will have a different timeline than a novel pesticide in India. After reviewing your specific case, we will provide you with realistic and accurate timelines for each target market.

What is the first step in working with Auxilife?

The first step is to contact us for a consultation. We will discuss your product, target markets, and objectives. Based on this, we can provide a preliminary assessment and a clear plan of action with a transparent fee structure.

Can you handle the entire dossier preparation process?

Absolutely. Our core competency is the preparation of compliant, high-quality registration dossiers that meet the specific format and content requirements of each national authority. We manage everything from data gap analysis and literature reviews to compiling summaries and submitting the complete application.

What if we only need help with a specific part of the registration process?

Yes, we offer flexible engagement models. Whether you need a full-service solution or support for a specific component, we can tailor our services to your exact needs. This includes regulatory strategy, toxicology summaries, review of literature, MSDS preparation, and responding to authority questions.

How does Auxilife assist in the OMRI certification process?

As an OMRI-registered consultant, we guide you through a clear, stepwise review process. Our preliminary assessment is designed to provide you with a confident and informed decision on whether to proceed with OMRI certification, setting you up for success from the outset.

Can Auxilife assist in finding an efficient GLP-certified lab for our agrochemical studies?

Yes. Auxilife has legal collaborations with leading labs in India and a strong liaison with foreign labs. We will assist you in choosing a suitable and efficient GLP-certified laboratory for your required studies.

How do you stay updated with constantly changing regulations?

Regulatory monitoring is a core part of our service. Our team continuously tracks updates and changes in legislation across all the markets we serve. We proactively inform our clients of changes that may impact their products. You can also follow our updates via our LinkedIn marketing posts every Tuesday and our monthly newsletter.

How do you ensure the confidentiality of our product information?

Client confidentiality is paramount. We operate under strict Non-Disclosure Agreements (NDAs) and maintain robust internal data security protocols. Your intellectual property and proprietary data are treated with the utmost care and security.

CDSCO Prior Intimation System for Form CT-05 Export Approvals

CDSCO Prior Intimation System: The Central Drugs Standard Control Organization (CDSCO) has implemented a new Prior Intimation System for Form CT-05 applications, which will take effect on April, 2026. Following Gazette Notification G.S.R. 50(E), certain export-related applications are being transitioned from a prior-approval model to an immediate acknowledgement system.

Key Highlights:

Faster Processing: Digital submission using the Sugam portal generates an instant acknowledgement, known as “prior intimation,” allowing applicants to proceed without waiting for formal permission.
Strict Scope: The system is limited to export-purpose bioavailability or bioequivalence (BA/BE) investigations in healthy adults for oral dose forms.
Excluded Categories: Traditional permission is still required for cytotoxic pharmaceuticals, hormones, opioids, psychiatric substances, and medications with a limited therapeutic index.
Eligibility: Restricted to pharmaceuticals that have already been licensed in India or major worldwide markets (USA, EU, UK, Japan, Australia, Canada), with a research sample size of at least 18 individuals.
Regulatory Oversight: Applicants must obtain approval from a registered Ethics Committee, which must keep specified records for these studies for future CDSCO inspections.

This CDSCO circular represents a major step in reducing the regulatory burden on Indian exporters while upholding clinical safety standards.